Status:
COMPLETED
Maintenance of Platelet Inhibition With Cangrelor
Lead Sponsor:
The Medicines Company
Conditions:
Acute Coronary Syndrome (ACS)
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessiv...
Eligibility Criteria
Inclusion
- Written informed consent
- 18 Years of Age
- Non emergent coronary bypass graft surgery
- Received a thienopyridine within 48 hours prior to enrollment
Exclusion
- Confirmed or suspected pregnancy
- Cerebrovascular accident within one yar
- Intracranial neoplasm
- History of bleeding diathesis
- Thrombocytopenia
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
221 Patients enrolled
Trial Details
Trial ID
NCT00767507
Start Date
October 1 2008
End Date
July 1 2011
Last Update
April 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Clinic / Scripps Green Hospital
La Jolla, California, United States, 92037